Epidemiological analysis of all vena cava filter placement over 9 years in Brazil: trends and mortality rates in a population of over 200 million
Authors:
- Clara Sanches BuenoCBClara Sanches Bueno
- Hedra Marques SantosHSHedra Marques Santos
- Júlia Freire CastanheiraJCJúlia Freire Castanheira
- Bruno Jeronimo PonteBPBruno Jeronimo Ponte
- Felipe Soares Oliveira PortelaFPFelipe Soares Oliveira Portela
- Marcelo Fiorelli Alexandrino da SilvaMSMarcelo Fiorelli Alexandrino da Silva
- Marcelo Passos TeivelisMTMarcelo Passos Teivelis
- Alexandre FioranelliAFAlexandre Fioranelli
- Nelson WoloskerNWNelson Wolosker
Preprint
Abstract
Background: Venous thromboembolism (VTE) is a major global health concern, with inferior vena cava filters (VCFs) serving as an alternative to anticoagulation in high-risk patients. Brazil’s VCF trends remain understudied, particularly in its dual public-private healthcare system. This database study allows a broad overview of the Brazilian healthcare landscape. Methods: This retrospective nationwide analysis used Brazilian public (SUS/TabNet) and private (ANS/D-TISS) healthcare databases (2015–2023) to assess VCF placement rates, regional disparities and in-hospital mortality. Data included 21,630 procedures, analyzed via generalized linear models (Gamma/Poisson distributions). Results: The private system performed 57% of VCFs (12,323) despite covering only 25% of the population, with a 4.25-fold higher procedure rate per capita than the public system (29.45 vs. 6.42 per million). Women accounted for 57.8% of recipients. The Southeast region dominated (70% private, 40.5% public), while the North and Midwest had the lowest rates. Mortality rates were comparable (public 6.7% vs. private 7.4%, p = 0.066), peaking during COVID-19. Procedure volumes rose 140% over 9 years, contrasting with declining U.S. trends post-FDA restrictions. Conclusions: Brazil’s VCF use reflects systemic inequities, with private-system overrepresentation and regional gaps. This study enables unprecedented insights into large-scale VCF implementation across diverse healthcare subsystems.Keywords
This publication has 28 references indexed in Scilit:
- Postmarketing Surveillance of Inferior Vena Cava Filters Among US Medicare BeneficiariesJAMA, 2024
- Epidemiology and prevention of venous thromboembolismNature Reviews Cardiology, 2022
- Sex‐specific aspects of venous thromboembolism: What is new and what is next?Research and Practice in Thrombosis and Haemostasis, 2022
- The Need for a Vena Cava Filter in Oncological Patients with Acute Venous Thrombosis: A Marker of a Worse PrognosisAnnals of Vascular Surgery, 2019
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesEuropean Heart Journal, 2019
- Trends in Inferior Vena Cava Filter Placement by Indication in the United States From 2005 to 2014JAMA Internal Medicine, 2017
- The epidemiology of venous thromboembolismJournal of Thrombosis and Thrombolysis, 2016
- The Brazilian health system: history, advances, and challengesThe Lancet, 2011
- Guidelines for the use of retrievable and convertible vena cava filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus ConferenceSurgery for Obesity and Related Diseases, 2006
- A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1998